UNSPSC 51283413: Rotamicillin

This classification denotes a penicillin antibiotic with the molecular formula C28H31N5O5S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier JS13873052, chemically known as (2s,5r,6r)-3,3-dimethyl-7-oxo-6-((r)-2-phenyl-2-(2-(4-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetamido(acetamido-4-thia-1-azabicyclo(3.2.0)heptan-2-carboxylic acid but more generally known as rotamicillin, which bears U.S. National Institutes of Health Compound Identifier 3058737.

UNSPSC 51283413 Rotamicillin is a Commodity code representing a specific antibiotic pharmaceutical product; however, the recent state and local contract opportunities tagged under this code do not align with rotamicillin procurement. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida released an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems. These solicitations reflect state health departments and counties sourcing antibiotics and emergency-response pharmaceuticals through cooperative purchasing vehicles and competitive sealed bids, but neither procurement involves rotamicillin itself. The issuing bodies are primarily state public health agencies and county governments using IFB and piggyback arrangements to manage pharmaceutical supply chains on multi-year terms with renewal options.

The recent activity appears concentrated in Florida and Illinois, though the opportunities tagged under this code do not support a broader geographic characterization. The Illinois contract awarded to Chartwell Rx LLC totaled $2,999,999.11 over three years including renewals, with an initial 12-month term and options for years two and three; the Seminole County procurement sought annual quantities of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems on a two-year initial term with one-year renewal option, with quarterly deliveries to the county community health building in Sanford. The code's current tagging appears to reflect a data-classification mismatch — the recent opportunities involve related pharmaceuticals rather than rotamicillin specifically, suggesting either miscoding by the issuing bodies or a broader pharmaceutical-supply aggregation in the underlying dataset. Businesses pursuing rotamicillin sales to state and local health systems should monitor pharmaceutical commodity codes more broadly and track cooperative purchasing vehicle catalogs such as MMCAP Infuse.